InsidersTradesSigma
Track the REVOLUTION MEDICINES INC share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €44.6bn. The latest transaction was disclosed on 21 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MARGARET A HORN. All data is free.
Analysts rate REVOLUTION MEDICINES INC Strong Buy (bullish), based on 21 analysts. Average price target: US$247.11.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
REVOLUTION MEDICINES INC 是一家生物制药公司，专注于开发针对癌症的靶向治疗药物。它采用创新方法来识别和开发阻断肿瘤特异性信号通路的药物。